Abstract: PO0368
PKM2-Specific Deletion in Myeloid Cells Ameliorates Renal Impairment by Alleviating Metabolic Changes in CaOx-Induced AKI
Session Information
- AKI: Mechanisms of Injury
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: Acute Kidney Injury
- 103 AKI: Mechanisms
Authors
- Foresto-Neto, Orestes, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Honda, Tâmisa Seeko, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Silva, Magaiver Andrade, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Watanabe, Ingrid Kazue Mizuno, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Basso, Paulo Jose, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Jesus, Iris Carvalho, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- da Silva, Ana Ruth Paolinetti Alves, Universidade Federal de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Cenedeze, Marcos A., Universidade Federal de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Hiyane, Meire Ioshie, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Alves-Filho, José C., Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Zatz, Roberto, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Pacheco-Silva, Alvaro, Universidade Federal de Sao Paulo, Sao Paulo, São Paulo, Brazil
- Camara, Niels Olsen Saraiva, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
Background
Macrophages are plastic cells and can polarize towards pro- or anti-inflammatory phenotype. PKM2 catalyzes the last step of glycolysis, which is a crucial metabolic pathway for activation of macrophages. We investigated whether deletion of PKM2 in myeloid cells would interfere with renal metabolism and exert protection in calcium oxalate (CaOx) crystal-induced acute kidney disease (AKI).
Methods
Myeloid-specific PKM2-knockout mice (PKM2fl/fl;LysM-Cre+) and their Cre-negative littermates (PKM2fl/fl) underwent AKI by a single i.p. injection of NaOx (100mg/kg) and 3% NaOx in drinking water for 24hr before sacrifice. Expression of PKM2 in bone marrow-derived macrophages was assessed by FACS. Serum creatinine, blood urea, renal CaOx crystal deposition (Pizzolato staining), IL-6, NGAL, KIM-1, HK2, CPT1a and CPT2 mRNA expression (quantitative PCR), macrophage number/phenotype (FACS), and lactate levels were all measured.
Results
In PKM2fl/fl, intrarenal CaOx deposition impaired renal function, as well as increased the expression of IL-6, NGAL, KIM-1 and HK2 and the levels of lactate in kidneys compared to healthy controls (p<0.05). Renal expression of CPT1a and CPT2 did not differ among groups. PKM2fl/fl;LysM-Cre+ exhibited similar deposition of crystals but less impairment of renal function, inflammation/injury and renal lactate content (p<0.05). The number of F4/80+CD11b+ cells in kidneys were similarly elevated by CaOx in both PKM2fl/fl and PKM2fl/fl;LysM-Cre+, while pro-inflammatory macrophages (Ly6C+CD206-) were significantly reduced in PKM2;LysM-Cre+ mice (p<0.01).
Conclusion
Pro-inflammatory macrophages rely mainly on glycolysis in oxalate induced-AKI. Deletion of PKM2 in myeloid cells partially prevents renal metabolic changes and inflammation/injury. FAPESP (2019/02893-9 and 2017/05264-7), CNPq and CAPES (Financial Code 001).
Funding
- Government Support – Non-U.S.